Oncology
ASCO 2024 - Chris Haqq interview with Jonah Comstock

ASCO 2024 - Chris Haqq

ASCO isn’t just a show for top 10 pharmas and Phase 3 readouts; it’s also a conference where smaller biopharmas share encouraging early-stage results, especially those that point to a new p

Oncology
ASCO 2024 - Steve Devine interview with Jonah Comstock

ASCO 2024 - Steve Devine

While advances in cell and gene therapies chip away at the need for bone marrow transplants, the transplantation field remains very much alive and in the midst of innovations of its own.

Oncology
Michael Petroutsas at ASCO 2024

ASCO 2024 - Michael Petroutsas

Just two months into his new position as US president and head of commercial for Astellas, Michael Petroutsas joined pharmaphorum editor-in-chief Jonah Comstock for a conversation on the si

Sales & Marketing

Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Digital

Digital
lady pointing at a number of data points
Sponsored

Solution Spotlight: Medscape AI

Medscape AI introduces a global, medical-grade AI search tool exclusively curated from the world’s largest body of clinically vetted content.

Market Access

Editor's Picks

  1. US pharma tariffs of up to 100% finalised by Trump
  2. Lilly bags FDA okay for Wegovy pill rival orforglipron
  3. Eli Lilly makes $7.8bn takeover play for Centessa
  4. Blackstone closes record $6.3bn life sciences fund
  5. One in four diabetics has undiagnosed heart failure; study

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more